-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Osaka Prefecture Adult Disease Center in Japan has announced that it will launch a "cancer cell bank" that can hold cancer patients' cancer cells from April next year, and that in the future, these preserved cancer cells can be used in personalized cancer medicine and the development of anti-cancer drugs in collaboration with pharmaceutical companies and research institutions.
, the spread of cancer cells and drug therapy are different from person to person. Personalized medicine requires targeted study of an individual patient's cancer cells, but cancerous tissue cut during surgery usually dies quickly and is difficult to use in laboratories for drug testing.
this "cancer cell bank" collects cancer cells removed from the patient and cultures them properly, then freezes them with liquid nitrogen and thaws them when needed, allowing them to get "living cancer cells" on demand. The center believes this could enhance personalized cancer care, such as drug testing of cancer cells from the patient's own before the patient uses an anti-cancer agent, and choosing the best treatment.
center says 50 colorectal cancer cells and 30 lung cancer cells have been preserved. With the development of the "cancer cell bank", pharmaceutical companies and other research institutions can also use preserved cancer cells to develop drugs. (China Science Journal)